Skip to main content
Meet us next:   BIO-EUROPE 2025 – 3-5 November  ●  ISSCR International Symposium (Boston) 2025 – 11-12 December  ●  more on our events calendar

Histocell obtains AEMPS authorisation and GMP certification for its new manufacturing plant for cell therapy and associated biological medicinal products in Larrabetzu

REPROCELL's clinical stem cells manufacturing partner Histocell has obtained AEMPS authorisation and GMP certification for its new manufacturing plant, that is located in Larrabetzu, Spain. Histocell's manufacturing plant  produces cell therapy and associated biological medicinal products.

Read Histocell's press release (offsite )

See REPROCELL's GMP MSC production servicespage for more information.